175 results on '"Welzel, Tatjana"'
Search Results
2. COVID-19 Vaccine Acceptance Among Parents of Children With Multisystem Inflammatory Syndrome in Children
3. Cardiac assessment and inflammatory markers in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV2 (PIMS-TS) treated with methylprednisolone versus intravenous immunoglobulins: 6-month follow-up outcomes of the randomised controlled Swissped RECOVERY trial
4. Prospective study to characterize adalimumab exposure in pediatric patients with rheumatic diseases
5. Efficacy and Safety of NSAIDs in Infants: A Comprehensive Review of the Literature of the Past 20 Years
6. MKD bei Kindern und Jugendlichen
7. CAPS bei Kindern und Jugendlichen
8. TRAPS bei Kindern und Jugendlichen
9. Optimized Treatment of Interleukin (IL-1)-Mediated Autoinflammatory Diseases: Impact of Disease Activity-Based Treatment Adjustments
10. Update systemische juvenile idiopathische Arthritis
11. Tapering of biological treatment in autoinflammatory diseases: a scoping review
12. Modeling of levothyroxine in newborns and infants with congenital hypothyroidism: challenges and opportunities of a rare disease multi-center study
13. MKD bei Kindern und Jugendlichen
14. CAPS bei Kindern und Jugendlichen
15. TRAPS bei Kindern und Jugendlichen
16. Patient Experiences and Challenges in the Management of Autoinflammatory Diseases—Data from the International FMF & AID Global Association Survey
17. Nachrichten der Gesellschaft für Kinder- und Jugendrheumatologie
18. Monitoring the recovery time of children after tonsillectomy using commercial activity trackers
19. Colchicine – an effective treatment for children with a clinical diagnosis of autoinflammatory diseases without pathogenic gene variants
20. Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology – what we know and what we do not know from randomized controlled trials
21. Correction to: Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology – what we know and what we do not know from randomized controlled trials
22. CAPS bei Kindern und Jugendlichen
23. TRAPS bei Kindern und Jugendlichen
24. Cryopyrin-assoziierte periodische Syndrome
25. Clinically practical pharmacometrics computer model to evaluate and personalize pharmacotherapy in pediatric rare diseases: application to Graves' disease
26. Methylprednisolone versus intravenous immunoglobulins in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): an open-label, multicentre, randomised trial
27. Arthrite juvénile idiopathique systémique, une mise au point
28. Use of a personalized phenytoin dosing approach to manage difficult to control seizures in an infant with a SCN2A mutation
29. Comment on: Effective ex vivo inhibition of cryopyrin-associated periodic syndrome (CAPS)-associated mutant NLRP3 inflammasome by MCC950/CRID3: Reply
30. Methylprednisolone versus intravenous immunoglobulins in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): an open-label, multicentre, randomised trial
31. Double trouble: visceral leishmaniasis in twins after traveling to Tuscany – a case report
32. Nachrichten der Gesellschaft für Kinder- und Jugendrheumatologie
33. Understanding efficacy-safety balance of biologics in moderate-to-severe pediatric psoriasis
34. Vaccination completeness in children with rheumatic diseases: A longitudinal, observational multicenter cohort study in Switzerland
35. PFAPA syndrome in children: Regional disparities and delay to the diagnosis
36. Treat-to-target in Interleukin-1 mediated autoinflammatory diseases
37. Value of Literature Review to Inform Development and Use of Biologics in Juvenile Idiopathic Arthritis
38. Variant in the PLCG2 Gene May Cause a Phenotypic Overlap of APLAID/PLAID: Case Series and Literature Review
39. Multicenter Randomized Trial of Methylprednisolone vs. Intravenous Immunoglobulins to Treat the Pediatric Inflammatory Multisystem Syndrome—Temporally Associated With SARS-CoV-2 (PIMS-TS): Protocol of the Swissped RECOVERY Trial
40. Effective ex vivo inhibition of cryopyrin-associated periodic syndrome (CAPS)-associated mutant NLRP3 inflammasome by MCC950/CRID3
41. Additional file 1 of Tapering of biological treatment in autoinflammatory diseases: a scoping review
42. Seltene Blutungslokalisation - seltene Diagnose
43. Colchicine Effectiveness and Safety in Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenitis
44. Principes du dosage médicamenteux chez les enfants
45. Prinzipien der medikamentösen Dosierung bei Kindern
46. Additional file 1 of Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology – what we know and what we do not know from randomized controlled trials
47. Management of Monogenic IL-1 Mediated Autoinflammatory Diseases in Childhood
48. Corrigendum to: Age appropriate reference intervals for eight kidney function and injury markers in infants, children and adolescents
49. COVID-19 in Autoinflammatory Diseases with Immunosuppressive Treatment
50. Diagnosis and Management of the Cryopyrin-Associated Periodic Syndromes (CAPS): What Do We Know Today?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.